Over half a million Californians could lose access to the hugely popular GLP-1 weight loss drugs starting Jan. 1, 2026, after ...

Artificial Intelligence is growing fast, and professionals now need both data science knowledge and Generative AI skills. These programs teach solid technical basics along with fundamental GenAI tools ...

The International Diabetes Federation (IDF) officially recognized a fifth form of the disease this year, a landmark step that ...

Poppy’s love for putting smiles on the faces of patients and family members she visits at MUSC Health University Medical ...

Americans in five states who get government help paying for groceries will see new limits on soda, candy and other foods they ...

The study also found that women with a history of GLP-1 use had a 30% higher risk of developing gestational diabetes, a ...

From prescriptions to hospitals to Medicaid, President Donald Trump's healthcare vision, with eligibility changes, will come ...

The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.

The efforts are aimed at reducing chronic diseases such as obesity and diabetes associated with sweetened drinks and other ...

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...

Mississippi has received over $205 million from the Centers for Medicare & Medicaid Services to improve health care in rural ...